The Daily Overview on MSN
Eli Lilly closes in on a deal to buy biotech Ventyx
Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...
KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...
A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...
A Type B meeting between the FDA and Plus Therapeutics offered clarity and direction for the next steps in development of ...
Ukko Inc. has announced plans to initiate clinical trials with UKK-0018 for peanut allergy in the first half of this year.
While Alzheimer’s disease is known for involving amyloid-b plaques and neurofibrillary tangles, it also involves metabolic dysfunction, further research into which could help scientists understand how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback